ZA859526B - Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them - Google Patents
Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing themInfo
- Publication number
- ZA859526B ZA859526B ZA859526A ZA859526A ZA859526B ZA 859526 B ZA859526 B ZA 859526B ZA 859526 A ZA859526 A ZA 859526A ZA 859526 A ZA859526 A ZA 859526A ZA 859526 B ZA859526 B ZA 859526B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- substituted
- tryptophan
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT68241/84A IT1179866B (it) | 1984-12-12 | 1984-12-12 | Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA859526B true ZA859526B (en) | 1986-08-27 |
Family
ID=11308641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA859526A ZA859526B (en) | 1984-12-12 | 1985-12-12 | Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4870097A (da) |
| EP (1) | EP0237522B1 (da) |
| JP (1) | JPS62501292A (da) |
| AT (1) | ATE85976T1 (da) |
| AU (1) | AU589938B2 (da) |
| CA (1) | CA1256441A (da) |
| DE (1) | DE3587122T2 (da) |
| DK (1) | DK168564B1 (da) |
| ES (1) | ES8706630A1 (da) |
| IE (1) | IE58502B1 (da) |
| IT (1) | IT1179866B (da) |
| PT (1) | PT81674B (da) |
| WO (1) | WO1986003489A1 (da) |
| ZA (1) | ZA859526B (da) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4814463A (en) * | 1985-12-31 | 1989-03-21 | Biomeasure, Inc. | CCK antagonists |
| US4880938A (en) * | 1986-06-16 | 1989-11-14 | Merck & Co., Inc. | Amino acid analogs |
| US5089638A (en) * | 1986-06-16 | 1992-02-18 | Merck & Co., Inc. | Amino acid analogs as CCK-antagonists |
| SE8901149D0 (sv) * | 1989-04-03 | 1989-04-03 | Pharmacia Ab | Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat |
| US5360814A (en) * | 1991-02-28 | 1994-11-01 | Merrell Dow Pharmaceuticals Inc. | NMDA antagonists |
| DK0501378T3 (da) * | 1991-02-28 | 1995-03-20 | Merrell Dow Pharma | NMDA-antagonister |
| US5484814A (en) * | 1991-02-28 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | NMDA antagonists |
| US20030199523A1 (en) * | 2002-02-28 | 2003-10-23 | Snutch Terrance P. | Heterocyclic calcium in channel blockers |
| PT1549333E (pt) | 2002-09-20 | 2012-01-03 | Univ Pennsylvania | Análogos de compstatina com actividade melhorada |
| US8168584B2 (en) | 2005-10-08 | 2012-05-01 | Potentia Pharmaceuticals, Inc. | Methods of treating age-related macular degeneration by compstatin and analogs thereof |
| EP2662089A3 (en) | 2005-10-08 | 2014-02-19 | Potentia Pharmaceuticals, Inc. | Compstatin and analogs thereof for eye disorders |
| CN102977191B (zh) | 2005-11-28 | 2016-08-10 | 宾夕法尼亚州大学理事会 | 有效的c3补体抑制素类似物 |
| HUE026001T2 (en) | 2007-02-05 | 2016-04-28 | Apellis Pharmaceuticals Inc | Compstatin analogues for use in the treatment of the inflammatory condition of the respiratory system |
| CA2760839C (en) | 2009-05-01 | 2019-02-12 | The Trustees Of The University Of Pennsylvania | Modified compstatin with peptide backbone and c-terminal modifications |
| CA2813049A1 (en) | 2010-09-23 | 2012-03-29 | The Trustees Of The University Of Pennsylvania | Modified compstatin with improved stability and binding properties |
| JP2014503592A (ja) | 2011-01-26 | 2014-02-13 | ニコ ワールドワイド,インコーポレイテッド | 片頭痛の療法 |
| MX356528B (es) | 2011-05-11 | 2018-06-01 | Apellis Pharmaceuticals Inc | Analogos de compstatina de celula reactiva, de acción prolongada u objetivos y usos de los mismos. |
| EP3524258B1 (en) | 2011-06-22 | 2025-10-01 | Apellis Pharmaceuticals, Inc. | Methods of treating chronic disorders with complement inhibitors |
| CA2847862C (en) | 2011-09-07 | 2021-01-12 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved pharmacokinetic properties |
| MX366404B (es) | 2012-11-15 | 2019-07-08 | Apellis Pharmaceuticals Inc | Analogos de compstatina de celula reactiva, de acción prolongada u objetivos y composiciones y metodos relacionados. |
| WO2014152391A1 (en) | 2013-03-15 | 2014-09-25 | Apellis Pharmaceuticals, Inc. | Cell-penetrating compstatin analogs and uses thereof |
| US10213476B2 (en) | 2014-03-17 | 2019-02-26 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with improved potency and pharmacokinetic properties |
| US11903994B2 (en) | 2015-10-07 | 2024-02-20 | Apellis Pharmaceuticals, Inc. | Dosing regimens |
| EP3374027B1 (en) * | 2015-11-12 | 2021-06-23 | The Trustees of Columbia University in the City of New York | Rational drug design targeting resistant gram-negative bacterial infections to polymyxin-class antibiotics |
| IL269844B2 (en) | 2017-04-07 | 2025-01-01 | Apellis Pharmaceuticals Inc | Dosage regimens and related compositions and methods |
| AU2018260628A1 (en) | 2017-04-25 | 2019-12-12 | Temple Otorongo Llc | Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions |
| WO2019118938A1 (en) | 2017-12-15 | 2019-06-20 | Apellis Pharmaceuticals, Inc. | Dosing regimens and related compositions and methods |
| EP4011905A3 (en) | 2018-04-06 | 2022-06-29 | The Trustees Of The University Of Pennsylvania | Compstatin analogs with increased solubility and improved pharmacokinetic properties |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1055518B (it) * | 1971-05-18 | 1982-01-11 | Rotta Research Lab | Derivatives del triptofano |
| US4482567A (en) * | 1982-10-07 | 1984-11-13 | Research Foundation For Mental Hygiene, Inc. | N-hexanoyl to n-heptadecanoyl 5-hydroxy tryptophan-5-hydroxytryptophanamides and use as analgesics |
-
1984
- 1984-12-12 IT IT68241/84A patent/IT1179866B/it active
-
1985
- 1985-12-02 IE IE302985A patent/IE58502B1/en not_active IP Right Cessation
- 1985-12-05 DE DE8686900106T patent/DE3587122T2/de not_active Expired - Fee Related
- 1985-12-05 EP EP86900106A patent/EP0237522B1/en not_active Expired - Lifetime
- 1985-12-05 AT AT86900106T patent/ATE85976T1/de active
- 1985-12-05 WO PCT/EP1985/000672 patent/WO1986003489A1/en not_active Ceased
- 1985-12-05 AU AU52099/86A patent/AU589938B2/en not_active Ceased
- 1985-12-05 JP JP61500191A patent/JPS62501292A/ja active Pending
- 1985-12-09 CA CA000497174A patent/CA1256441A/en not_active Expired
- 1985-12-11 ES ES549822A patent/ES8706630A1/es not_active Expired
- 1985-12-12 PT PT81674A patent/PT81674B/pt not_active IP Right Cessation
- 1985-12-12 ZA ZA859526A patent/ZA859526B/xx unknown
-
1986
- 1986-08-11 DK DK381486A patent/DK168564B1/da not_active IP Right Cessation
-
1988
- 1988-07-11 US US07/217,116 patent/US4870097A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986003489A1 (en) | 1986-06-19 |
| DE3587122T2 (de) | 1993-07-15 |
| DK381486D0 (da) | 1986-08-11 |
| EP0237522B1 (en) | 1993-02-24 |
| IT8468241A0 (it) | 1984-12-12 |
| IT8468241A1 (it) | 1986-06-12 |
| ES8706630A1 (es) | 1987-06-01 |
| JPS62501292A (ja) | 1987-05-21 |
| AU5209986A (en) | 1986-07-01 |
| US4870097A (en) | 1989-09-26 |
| IE58502B1 (en) | 1993-10-06 |
| EP0237522A1 (en) | 1987-09-23 |
| ES549822A0 (es) | 1987-06-01 |
| IE853029L (en) | 1986-06-12 |
| CA1256441A (en) | 1989-06-27 |
| PT81674B (pt) | 1987-10-20 |
| DK168564B1 (da) | 1994-04-25 |
| IT1179866B (it) | 1987-09-16 |
| DK381486A (da) | 1986-08-11 |
| AU589938B2 (en) | 1989-10-26 |
| ATE85976T1 (de) | 1993-03-15 |
| DE3587122D1 (de) | 1993-04-01 |
| PT81674A (en) | 1986-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA859526B (en) | Pharmaceutically active derivatives of tryptophan and pharmaceutical compositions containing them | |
| DK202882A (da) | Fremgangsmaade til fremstilling af 1-alkyl-2-aminotetralinderivater | |
| HUT70502A (en) | Amidino derivatives, pharmaceutical compns. contg. them and process to prepare them | |
| ATE89731T1 (de) | Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis. | |
| ZA879280B (en) | Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds | |
| IL79910A (en) | 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them | |
| PT77666A (fr) | Procede de preparation de nouveaux derives de la nitrosouree | |
| GB2152508A (en) | Pyrimidine derivatives | |
| DE2962856D1 (en) | Hexahydro-1,4-oxazepines, process for their preparation and pharmaceutical compositions containing them | |
| ZA858030B (en) | Thiadiazole derivatives active on the central nervous system,process for their preparation and pharmaceutical compositions in which they are present | |
| BE896098A (fr) | Procede de modulation de la reponse immunitaire avec des dibenzocycloheptenylidenes | |
| MX11977A (es) | Derivados de 1-bencil-2-oxo-5-alcoxi-pirrolidina y procedimiento para su preparacion. | |
| IT1254745B (it) | Ciclofosfazeni contenenti gruppi di acido acetil salicilico, procedimento di preparazione ed utilizzazione |